Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.17%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 11.73Close
$ 5.31 - $ 12.34 52-Week Range
Ticker Information
Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREGENXBIO INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RGNX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 15.84M | 10.17% | $ 155.78M |
| 3/31/2025 | $ 15.99M | 10.2% | $ 156.72M |
| 12/31/2024 | $ 16.21M | 19.46% | $ 83.33M |
| 9/30/2024 | $ 16.53M | 19.6% | $ 84.33M |
| 6/30/2024 | $ 16.94M | 19.02% | $ 89.04M |
| 3/31/2024 | $ 17.32M | 19.97% | $ 86.73M |
| 12/31/2023 | $ 17.32M | 19.19% | $ 90.24M |
| 9/30/2023 | $ 17.11M | 17.22% | $ 99.37M |
| 6/30/2023 | $ 16.29M | 16.8% | $ 96.97M |
| 3/31/2023 | $ 14.5M | 13.22% | $ 109.64M |
Key Performance Insights, Last 5 Years
- REGENXBIO INC's latest trailing twelve months (TTM) DepAmor % stands at 5.68%.
- Over the past 5 years, REGENXBIO INC's average DepAmor % has been 10.82%.
- The median DepAmor % for REGENXBIO INC during this period was 10.19%
- REGENXBIO INC reached its highest DepAmor % over the past 5 years at 19.97%.
- The lowest DepAmor % recorded by REGENXBIO INC in the same timeframe 2.03%
REGENXBIO INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for REGENXBIO INC is calculated as follows: DepAmor [ $ 8.22M ] / Revenues [ $ 144.89M ]
(=) DepAmor % [ 5.68% ] RGNX - Depreciation and Amortization Margin, Last 5 years
2.03%
Minimum
Dec 31, 2021
19.97%
Maximum
Mar 31, 2024
10.82%
Average
10.19%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |